Ads
related to: drug for gonorrhea
Search results
Results from the WOW.Com Content Network
A new antibiotic has proven as effective as the last remaining recommended treatment for gonorrhea, helping to assuage mounting fears among public health experts about the emergence of drug ...
Gonorrhea if left untreated may last for weeks or months with higher risks of complications. [19] One of the complications of gonorrhea is systemic dissemination resulting in skin pustules or petechia, septic arthritis, meningitis, or endocarditis. [19] This occurs in between 0.6 and 3% of infected women and 0.4 and 0.7% of infected men. [19]
Spectinomycin, sold under the tradename Trobicin among others, is an antibiotic useful for the treatment of gonorrhea infections. [2] It is given by injection into a muscle. [2] Common side effects include pain at the area of injection, rash, nausea, fever, and trouble sleeping. [2] Severe allergic reactions may occasionally occur. [2]
Neisseria gonorrhoeae, the bacterium that causes the sexually transmitted infection gonorrhea, has developed antibiotic resistance to many antibiotics. The bacteria was first identified in 1879. [1] In the 1940s effective treatment with penicillin became available, but by the 1970s resistant strains predominated. Resistance to penicillin has ...
Antibiotic-resistant gonorrhea is rare in the U.S., but El Sahly says it’s still important to take it seriously. Dr. Matthew Hamill, an assistant professor of medicine at Johns Hopkins School of ...
A study out of the University of York shows that carbon monoxide-releasing molecules could be the key to developing a new antibiotic to treat gonorrhea.
Within N. gonorrhoeae, genes exist that confer resistance to every single antibiotic used to cure gonorrhea, but thus far they do not coexist within a single gonococcus. However, because of N. gonorrhoeae ' s high affinity for horizontal gene transfer, antibiotic-resistant gonorrhea is seen as an emerging public health threat. [81]
Zoliflodacin (development codes AZD0914 and ETX0914) is an experimental antibiotic that is being studied for the treatment of infection with Neisseria gonorrhoeae (). [1] It has a novel mechanism of action which involves inhibition of bacterial type II topoisomerases. [2]
Ads
related to: drug for gonorrhea